Ciclotizolam
A benzodiazepine derivative
Ciclotizolam is a benzodiazepine derivative that is used for its anxiolytic, hypnotic, and sedative properties. It is a member of the triazolobenzodiazepine class, which is characterized by the fusion of a triazole ring to the benzodiazepine structure.
Chemical Structure[edit]
Ciclotizolam has the chemical formula C17H12Cl2N4. The structure includes a triazole ring fused to the benzodiazepine core, with a chlorine atom at the 8-position and a 2-chlorophenyl group at the 6-position. This structure is responsible for its pharmacological activity.
Pharmacology[edit]
Ciclotizolam acts on the central nervous system by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA_A receptor. This action results in increased inhibitory neurotransmission, leading to its sedative and anxiolytic effects. Like other benzodiazepines, it is thought to increase the frequency of chloride channel opening events, which hyperpolarizes the neuron and makes it less excitable.
Uses[edit]
Ciclotizolam is primarily used for its sedative and anxiolytic effects. It is prescribed for the short-term treatment of insomnia and for the management of anxiety disorders. Due to its potential for tolerance, dependence, and withdrawal, it is generally recommended for short-term use only.
Side Effects[edit]
Common side effects of ciclotizolam include drowsiness, dizziness, and fatigue. More serious side effects can include respiratory depression, confusion, and impaired coordination. Long-term use can lead to tolerance and dependence, and abrupt discontinuation can result in withdrawal symptoms.
Legal Status[edit]
The legal status of ciclotizolam varies by country. In some jurisdictions, it is classified as a controlled substance due to its potential for abuse and dependence. It is important for prescribers to be aware of the legal regulations in their area.
Related Compounds[edit]
Ciclotizolam is related to other triazolobenzodiazepines such as alprazolam and triazolam. These compounds share similar pharmacological properties and are used for similar therapeutic purposes.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


